June 22, 2023
1 min watch
Save
VIDEO: Research points to ‘exciting’ time for perioperative lung cancer
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — Healio spoke with Karen L. Reckamp, MD, about research on perioperative lung cancer presented at ASCO .
“There are a lot of advances being made in the perioperative arena,” Reckamp, a professor in medicine and director of the division of medical oncology at Cedars-Sinai Medical Center, told Healio.
In addition to “practice-changing” research presented from the ADURA trial, she also discussed findings from the KEYNOTE-671 trial and the Neotorch study.
“This is an exciting time for the perioperative, potentially curable setting, really making a difference for patients with both immunotherapy and targeted therapy,” Reckamp said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Reckamp reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.